| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/05/2012 | US20120003307 Levetiracetam controlled release composition |
| 01/05/2012 | US20120003306 Pharmaceutical composition of nanoparticles for protein drug delivery |
| 01/05/2012 | US20120003305 Oral Dosage Forms Of Bendamustine |
| 01/05/2012 | US20120003303 Oral enteric antidepressant formulation |
| 01/05/2012 | US20120003301 Tissue markings and methods for reversibly marking tissue employing the same |
| 01/05/2012 | US20120003297 Compositions and methods for treating lymphoma |
| 01/05/2012 | US20120003295 Lipid a and other carbohydrate ligand analogs |
| 01/05/2012 | US20120003291 Nanobead releasing medical devices |
| 01/05/2012 | US20120003290 Method for reducing pain |
| 01/05/2012 | US20120003288 Dispersion composition and method for manufacturing dispersion composition |
| 01/05/2012 | US20120003282 Pharmaceutical compositions of dextran polymer derivatives |
| 01/05/2012 | US20120003275 Compositions and Methods for the Treatment of Ophthalmic Disease |
| 01/05/2012 | US20120003274 Oral sustained release antidepressant formulation |
| 01/05/2012 | US20120003273 Substituted benzfurochromenes and related compounds for the prevention and treatment of bone related disorders |
| 01/05/2012 | US20120003271 Polymer blends |
| 01/05/2012 | US20120003270 6-substituted isoflavonoid compounds and uses thereof |
| 01/05/2012 | US20120003264 CDNA Corresponding to the Antigenome of Nonsegmented Negative Stranded RNA Viruses and Process for the Production of Such Viruses |
| 01/05/2012 | US20120003252 Isoforms of human somatostatin receptor type 5 produced by alternative processing and oligo-nucleotide pairs for detection thereof by pcr |
| 01/05/2012 | US20120003244 Methods for apcdd1 mediated regulation of hair growth and pigmentation and mutants thereof |
| 01/05/2012 | US20120003243 Yeast ectopically expressing abnormally processed proteins and uses therefor |
| 01/05/2012 | US20120003242 Modulating pdx-1 with pcif1, methods and uses thereof |
| 01/05/2012 | US20120003228 Methods for predicting autoimmune disease risk |
| 01/05/2012 | US20120003227 Methods and compositions for the treatment and diagnosis of vascular inflammatory disorders or endothelial cell disorders |
| 01/05/2012 | US20120003220 B7-DC Variants |
| 01/05/2012 | US20120003219 Compositions and Methods to Treat Bone Related Disorders |
| 01/05/2012 | US20120003217 Herceptin® aduvant therapy |
| 01/05/2012 | US20120003215 Pyrazolo[1,5-a]pyrimidines for antiviral treatment |
| 01/05/2012 | US20120003209 Methods and kits used in identifying glioblastoma |
| 01/05/2012 | US20120003208 Compositions and methods for modulating vascular development |
| 01/05/2012 | US20120003207 Methods and compositions for modulating proline levels |
| 01/05/2012 | US20120003198 Lutein/Zeaxanthin for glare protection |
| 01/05/2012 | US20120003191 Valproic acid, derivatives, analogues, and compositions including same and methods for their therapeutic use |
| 01/05/2012 | US20120003189 Materials and Methods to Enhance Hematopoietic Stem Cells Engraftment Procedures |
| 01/05/2012 | US20120003184 Sodium salt of 5-cyclopropyl-2-benzoic acid as dhodh inhibitor |
| 01/05/2012 | US20120003183 Addition salts of tromethamine with azabiphenylaminobenzoic acid derivatives as dhodh inhibitors |
| 01/05/2012 | US20120003181 Novel Retinoid Inducible Factor and Uses Thereof |
| 01/05/2012 | US20120003177 Curcumin-containing polymers and water-soluble curcumin derivatives as prodrugs of prodrug carriers |
| 01/05/2012 | US20120003176 Hydrogel-forming composition comprising natural and synthetic segments |
| 01/05/2012 | US20120003175 Therapeutic uses of mastic gum fractions |
| 01/05/2012 | US20120003174 Otic compositions for the treatment of infections of the internal and external ear in mammals |
| 01/05/2012 | US20120003161 Use of inositol-tripyrophosphate in treating tumors and diseases |
| 01/05/2012 | US20120003158 Biomarkers for Inflammatory Bowel Disease and Methods Using the Same |
| 01/05/2012 | US20120003156 Methods for treating neoplasia by inhibiting lactate dehydrogenase and/or nicotinamide phosphoribosyltransferase |
| 01/05/2012 | US20120003153 Novel indolyl-oxadiazolyl-diazabicyclononane derivatives and their medical and diagnostical use |
| 01/05/2012 | US20120000998 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 01/05/2012 | US20120000806 Methods for reducing the risk of an adverse dronedarone / beta-blockers interaction in a patient suffering from atrial fibrilation |
| 01/05/2012 | DE102010030688A1 Substituierte Dicyanopyridine und ihre Verwendung Substituted dicyanopyridines and their use |
| 01/05/2012 | DE102010026090A1 Preparing a matrix for a sublingual dosage form, preferably a tablet, comprises preparing a mixture of gum arabic and active ingredients, and extruding the obtained mixture |
| 01/05/2012 | DE102010025864A1 Use of lucidone for treating hepatitis, preferably alcoholic hepatitis |
| 01/05/2012 | DE102010025786A1 Pyrazolochinoline Pyrazolochinoline |
| 01/05/2012 | CA2811061A1 Use of alpha-adrenergic receptor agonist for preventing or treating skin tumor |
| 01/05/2012 | CA2810746A1 Method for preventing or treating skin tumor |
| 01/05/2012 | CA2807303A1 Inhibition of inflammation by simultaneous blockade of multiple prostanoid receptors |
| 01/05/2012 | CA2804760A1 Single-walled carbon nanotube/sirna complexes and methods related thereto |
| 01/05/2012 | CA2804347A1 Heterocyclic alkynyl benzene compounds and medical compositions and uses thereof |
| 01/05/2012 | CA2804344A1 Calpain-3 inhibitors for treating muscular dystrophies and cardiomyopathies |
| 01/05/2012 | CA2804319A1 Benzofuran derivatives for the treatment of hepatits c |
| 01/05/2012 | CA2804225A1 Heterocyclic compound and p27kip1 degradation inhibitor |
| 01/05/2012 | CA2804201A1 Stable antiseptic compositions and methods |
| 01/05/2012 | CA2804197A1 Novel calcium salts of compound as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 01/05/2012 | CA2804194A1 Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response |
| 01/05/2012 | CA2804174A1 Molecular genetic approach to treatment and diagnosis of alcohol and drug dependence |
| 01/05/2012 | CA2804148A1 Transdermal drug delivery system containing donepezil |
| 01/05/2012 | CA2804147A1 Sustained release composition comprising an amine as active agent and a salt of a cyclic organic acid |
| 01/05/2012 | CA2804069A1 Pyrazoloquinolines |
| 01/05/2012 | CA2804016A1 L-methylfolate treatment for psychiatric or neurologic disorders |
| 01/05/2012 | CA2804001A1 Methods for treating post traumatic stress disorder |
| 01/05/2012 | CA2803983A1 Functional vascularization with biocompatible polysaccharide-based hydrogels |
| 01/05/2012 | CA2803971A1 Substituted dicyanopyridines and use thereof |
| 01/05/2012 | CA2803935A1 Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease |
| 01/05/2012 | CA2803879A1 Compositions and methods for modulating the wnt signaling pathway |
| 01/05/2012 | CA2803848A1 A process for etravirine intermediate and polymorphs of etravirine |
| 01/05/2012 | CA2803842A1 Novel nicotinamide derivative or salt thereof |
| 01/05/2012 | CA2803825A1 Phenylcarbamate compound and muscle relaxant containing the same |
| 01/05/2012 | CA2803721A1 Pharmaceutical composition comprising drospirenone and contraceptive kit |
| 01/05/2012 | CA2803668A1 Treatment of cognitive disorders |
| 01/05/2012 | CA2803665A1 2,4- diaryl - substituted [1,8] naphthyridines as kinase inhibitors for use against cancer |
| 01/05/2012 | CA2803660A1 Compound for inhibiting type 5 phosphodiesterase and preparation method thereof |
| 01/05/2012 | CA2803624A1 Heterocyclic compounds and their use as inhibitors of pi3k activity |
| 01/05/2012 | CA2803620A1 Heterocyclic compounds and their uses |
| 01/05/2012 | CA2803619A1 Heterocycle compounds and their uses |
| 01/05/2012 | CA2803577A1 2-pyridyl substituted imidazoles as therapeutic alk5 and/or alk4 inhibitors |
| 01/05/2012 | CA2803558A1 .omega.3 fatty acid compound preparation |
| 01/05/2012 | CA2803478A1 Novel tetrahydroquinoline derivatives |
| 01/05/2012 | CA2803446A1 Methods of targeting pten mutant diseases and compositions therefor |
| 01/05/2012 | CA2803444A1 Use of leukotriene b4 in combination with a toll-like receptor ligand, a rig-l-like receptor ligand or a nod-like receptor ligand to enhance the innate immune response |
| 01/05/2012 | CA2803358A1 Heterocyclic compounds and their use as inhibitors of pi3k activity |
| 01/05/2012 | CA2803292A1 Sgc stimulators |
| 01/05/2012 | CA2803259A1 Heterocyclic compounds and their use as inhibitors of pi3k activity |
| 01/05/2012 | CA2803257A1 Injectable pharmaceutical compositions for the treatment of joints |
| 01/05/2012 | CA2803031A1 A reconstituted high density lipoprotein formulation and production method thereof |
| 01/05/2012 | CA2802891A1 Use of a2b adenosine receptor antagonists for treating pulmonary hypertension |
| 01/05/2012 | CA2802816A1 Polymeric system for delivering a preservative-free prostaglandin-based nonviscous solution |
| 01/05/2012 | CA2802768A1 Recombinant tumor vaccine and method of producing such vaccine |
| 01/05/2012 | CA2802743A1 Apoptosis signal-regulating kinase inhibitors |
| 01/05/2012 | CA2802606A1 Formulations and delivery |
| 01/05/2012 | CA2802492A1 2-quinolinyl-acetic acid derivatives as hiv antiviral compounds |
| 01/05/2012 | CA2802380A1 3-amino-5,6-dihydro-1h-pyrazin-2-one derivatives useful for the treatment of alzheimer's disease and other forms of dementia |
| 01/05/2012 | CA2802303A1 Pharmaceutical compositions comprising paracetamol and process for preparing the same |
| 01/05/2012 | CA2802288A1 Fused heterocyclic compounds as ion channel modulators |